S&P 500   4,975.51 (-0.60%)
DOW   38,563.80 (-0.17%)
QQQ   427.32 (-0.75%)
AAPL   181.56 (-0.41%)
MSFT   402.79 (-0.31%)
META   471.75 (-0.33%)
GOOGL   141.12 (+0.43%)
AMZN   167.08 (-1.43%)
TSLA   193.76 (-3.10%)
NVDA   694.52 (-4.35%)
NIO   5.96 (-2.93%)
AMD   165.69 (-4.70%)
BABA   73.14 (-1.04%)
T   16.91 (-0.35%)
F   12.25 (-0.41%)
MU   80.71 (+1.52%)
CGC   3.54 (-7.33%)
GE   148.62 (-0.36%)
DIS   109.44 (-1.94%)
AMC   4.66 (-3.52%)
PFE   27.59 (-0.11%)
PYPL   58.63 (-0.86%)
XOM   102.75 (-0.94%)
S&P 500   4,975.51 (-0.60%)
DOW   38,563.80 (-0.17%)
QQQ   427.32 (-0.75%)
AAPL   181.56 (-0.41%)
MSFT   402.79 (-0.31%)
META   471.75 (-0.33%)
GOOGL   141.12 (+0.43%)
AMZN   167.08 (-1.43%)
TSLA   193.76 (-3.10%)
NVDA   694.52 (-4.35%)
NIO   5.96 (-2.93%)
AMD   165.69 (-4.70%)
BABA   73.14 (-1.04%)
T   16.91 (-0.35%)
F   12.25 (-0.41%)
MU   80.71 (+1.52%)
CGC   3.54 (-7.33%)
GE   148.62 (-0.36%)
DIS   109.44 (-1.94%)
AMC   4.66 (-3.52%)
PFE   27.59 (-0.11%)
PYPL   58.63 (-0.86%)
XOM   102.75 (-0.94%)
S&P 500   4,975.51 (-0.60%)
DOW   38,563.80 (-0.17%)
QQQ   427.32 (-0.75%)
AAPL   181.56 (-0.41%)
MSFT   402.79 (-0.31%)
META   471.75 (-0.33%)
GOOGL   141.12 (+0.43%)
AMZN   167.08 (-1.43%)
TSLA   193.76 (-3.10%)
NVDA   694.52 (-4.35%)
NIO   5.96 (-2.93%)
AMD   165.69 (-4.70%)
BABA   73.14 (-1.04%)
T   16.91 (-0.35%)
F   12.25 (-0.41%)
MU   80.71 (+1.52%)
CGC   3.54 (-7.33%)
GE   148.62 (-0.36%)
DIS   109.44 (-1.94%)
AMC   4.66 (-3.52%)
PFE   27.59 (-0.11%)
PYPL   58.63 (-0.86%)
XOM   102.75 (-0.94%)
S&P 500   4,975.51 (-0.60%)
DOW   38,563.80 (-0.17%)
QQQ   427.32 (-0.75%)
AAPL   181.56 (-0.41%)
MSFT   402.79 (-0.31%)
META   471.75 (-0.33%)
GOOGL   141.12 (+0.43%)
AMZN   167.08 (-1.43%)
TSLA   193.76 (-3.10%)
NVDA   694.52 (-4.35%)
NIO   5.96 (-2.93%)
AMD   165.69 (-4.70%)
BABA   73.14 (-1.04%)
T   16.91 (-0.35%)
F   12.25 (-0.41%)
MU   80.71 (+1.52%)
CGC   3.54 (-7.33%)
GE   148.62 (-0.36%)
DIS   109.44 (-1.94%)
AMC   4.66 (-3.52%)
PFE   27.59 (-0.11%)
PYPL   58.63 (-0.86%)
XOM   102.75 (-0.94%)

Lisata Therapeutics (LSTA) Short Interest Ratio & Short Volume

$3.00
-0.12 (-3.85%)
(As of 05:12 PM ET)

Lisata Therapeutics Short Interest Data

Current Short Volume
10,600 shares
Previous Short Volume
62,400 shares
Change Vs. Previous Month
-83.01%
Dollar Volume Sold Short
$26,182.00
Short Interest Ratio / Days to Cover
0.7
Last Record Date
January 31, 2024
Outstanding Shares
8,139,000 shares
Float Size
6,470,000 shares
Short Percent of Float
0.16%
Today's Trading Volume
12,117 shares
Average Trading Volume
10,877 shares
Today's Volume Vs. Average
111%
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook
Short Selling Lisata Therapeutics ?

Sign up to receive the latest short interest report for Lisata Therapeutics and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

LSTA Short Interest Over Time

LSTA Days to Cover Over Time

LSTA Percentage of Float Shorted Over Time


Lisata Therapeutics Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
1/31/202410,600 shares $26,182.00 -83.0%0.2%0.7 $2.47
1/15/202462,400 shares $188,448.00 +4.5%1.0%3.7 $3.02
12/31/202359,700 shares $162,981.00 +497.0%0.9%3 $2.73
12/15/202310,000 shares $27,400.00 -82.1%0.2%0.5 $2.74
11/30/202355,800 shares $122,202.00 +17.5%0.8%2.8 $2.19
11/15/202347,500 shares $106,400.00 -13.0%0.7%2.2 $2.24
10/31/202354,600 shares $118,482.00 +10.5%0.8%2.6 $2.17
10/15/202349,400 shares $106,333.50 -11.6%0.7%1.5 $2.15
9/30/202355,900 shares $119,626.00 -23.8%0.8%1.9 $2.14
9/15/202373,400 shares $160,012.00 +17.6%1.1%2.5 $2.18
8/31/202362,400 shares $136,032.00 +16.4%0.9%2.1 $2.18
8/15/202353,600 shares $144,720.00 -2.9%0.8%2.2 $2.70
7/31/202355,200 shares $174,984.00 -12.0%0.8%1.9 $3.17
7/15/202362,700 shares $232,617.00 +3.8%1.0%3.8 $3.71
6/30/202360,400 shares $223,480.00 -11.3%0.9%3.8 $3.70
6/15/202368,100 shares $288,063.00 +4.0%1.0%4.4 $4.23
5/31/202365,500 shares $268,550.00 +22.4%1.0%4.8 $4.10
5/15/202353,500 shares $181,365.00 No Change0.8%3.8 $3.39













LSTA Short Interest - Frequently Asked Questions

What is Lisata Therapeutics' current short interest?

Short interest is the volume of Lisata Therapeutics shares that have been sold short but have not yet been closed out or covered. As of January 31st, traders have sold 10,600 shares of LSTA short. 0.16% of Lisata Therapeutics' shares are currently sold short. Learn More on Lisata Therapeutics' current short interest.

What is a good short interest ratio for Lisata Therapeutics?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. LSTA shares currently have a short interest ratio of 1.0. Learn More on Lisata Therapeutics's short interest ratio.

Which institutional investors are shorting Lisata Therapeutics?

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Lisata Therapeutics: Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

What is a good short interest percentage for Lisata Therapeutics?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.16% of Lisata Therapeutics' floating shares are currently sold short.

Is Lisata Therapeutics' short interest increasing or decreasing?

Lisata Therapeutics saw a drop in short interest during the month of January. As of January 31st, there was short interest totaling 10,600 shares, a drop of 83.0% from the previous total of 62,400 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is Lisata Therapeutics' float size?

Lisata Therapeutics currently has issued a total of 8,140,000 shares. Some of Lisata Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Lisata Therapeutics currently has a public float of 6,470,000 shares.

How does Lisata Therapeutics' short interest compare to its competitors?

0.16% of Lisata Therapeutics' shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to Lisata Therapeutics: Aileron Therapeutics, Inc. (1.01%), Biora Therapeutics, Inc. (2.47%), Acasti Pharma Inc. (0.35%), Aprea Therapeutics, Inc. (3.19%), Lipocine Inc. (2.78%), TherapeuticsMD, Inc. (0.54%), SELLAS Life Sciences Group, Inc. (9.73%), NeuroBo Pharmaceuticals, Inc. (0.83%), Forte Biosciences, Inc. (0.14%), Lumos Pharma, Inc. (6.20%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($4.48 billion), General Motors ($3.85 billion), Charter Communications, Inc. ($3.38 billion), Occidental Petroleum Co. ($3.00 billion), Super Micro Computer, Inc. ($2.66 billion), Tractor Supply ($2.37 billion), Coinbase Global, Inc. ($2.25 billion), Moderna, Inc. ($2.11 billion), Royal Caribbean Cruises Ltd. ($2.06 billion), and Floor & Decor Holdings, Inc. ($1.67 billion). View all of the most shorted stocks.

What does it mean to sell short Lisata Therapeutics stock?

Short selling LSTA is an investing strategy that aims to generate trading profit from Lisata Therapeutics as its price is falling. LSTA shares are trading up $0.25 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Lisata Therapeutics?

A short squeeze for Lisata Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of LSTA, which in turn drives the price of the stock up even further.

How often is Lisata Therapeutics' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including LSTA, twice per month. The most recent reporting period available is January, 31 2024.



More Short Interest Resources from MarketBeat

This page (NASDAQ:LSTA) was last updated on 2/20/2024 by MarketBeat.com Staff